CN100374130C - Stasis expelling vessel freeing drip pill - Google Patents

Stasis expelling vessel freeing drip pill Download PDF

Info

Publication number
CN100374130C
CN100374130C CNB200510127400XA CN200510127400A CN100374130C CN 100374130 C CN100374130 C CN 100374130C CN B200510127400X A CNB200510127400X A CN B200510127400XA CN 200510127400 A CN200510127400 A CN 200510127400A CN 100374130 C CN100374130 C CN 100374130C
Authority
CN
China
Prior art keywords
drip
present
medicine
chinese medicine
pill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CNB200510127400XA
Other languages
Chinese (zh)
Other versions
CN1823952A (en
Inventor
于敏
王建军
王安起
樊庆银
苏谨
杨春雁
步广新
姜晓冬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANJING QIANHE PHARMACEUTICAL CO Ltd HAYAO GROUP
Original Assignee
SANJING QIANHE PHARMACEUTICAL CO Ltd HAYAO GROUP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANJING QIANHE PHARMACEUTICAL CO Ltd HAYAO GROUP filed Critical SANJING QIANHE PHARMACEUTICAL CO Ltd HAYAO GROUP
Priority to CNB200510127400XA priority Critical patent/CN100374130C/en
Publication of CN1823952A publication Critical patent/CN1823952A/en
Application granted granted Critical
Publication of CN100374130C publication Critical patent/CN100374130C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a stasis expelling vessel freeing drip pill which belongs to traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. The present invention has the advantages of effectively improved medical bioavailability, reliable curative effect, thorough treatment, fast absorption and convenient application. The present invention is characterized in that leeches, gadflies, peach kernels and rhubarb are used as a recipe, are respectively pulverized, and are mixed in a progressive increase method; after the materials are soaked by water, ultrasonic extraction is carried out; after ethanol is used for further ultrasonic treatment on filter residues, twice filter liquor is merged; afterwards, medicine powder is obtained through concentrating, drying and pulverizing; polyethylene glycol-6000 water solution solid substrate is uniformly mixed with the medicine powder to be made into the drip poll with the ratio of medicine to substrate of 1/2.4.

Description

Stasis expelling vessel freeing drip pill
Technical field
The present invention relates to a kind of pure Chinese medicinal preparation, in particular for treating the Chinese medicine prescription of the cardio-cerebralvascular diseases that causes by high viscous disease.
Background technology
" stasis expelling vessel freeing drip pill " existing capsule belongs to exclusive patented product of my company and Chinese medicine protection kind at present.For above-mentioned disease special efficacy is arranged all, but exist weakness such as big, the difficult absorption of taking dose, storage and transportation inconvenience.
Summary of the invention
Have deficiencies such as dosage is big, the slow bioavailability of absorption is low for overcoming above-mentioned dosage form, the objective of the invention is to provide a kind of stasis expelling vessel freeing drip pill, it can improve bioavailability of medicament effectively, absorbs fast, taking convenience, more remarkable treatment effect.
The technical solution adopted for the present invention to solve the technical problems is: with the prescription of following traditional Chinese medicines as this medicine.
Hirudo 500g Tabanus 20g
Semen Persicae 41.7g Radix Et Rhizoma Rhei 106.7g
The present invention adopts Polyethylene Glycol---6000 water solublity solid state substrates.
Technology: the Hirudo, Tabanus, Semen Persicae, Radix Et Rhizoma Rhei four Chinese medicine of getting recipe quantity are pulverized, and press incremental method and mix, and add 5 times water, soaked 24 hours, and in 40 ℃ of supersound extraction 20 minutes, filtration; Filtering residue, filters in 40 ℃ of supersound process 20 minutes with 70% ethanol, reclaims ethanol.Twice filtrate is merged, concentrates in 70 ℃ with the economic benefits and social benefits concentrator, extractum, drying is pulverized with pulverizer, must medicated powder.Press medicine and substrate than 1: 2.4 mixing, control material temperature is in 90 ℃, and 70 ℃ of condensation temperatures to drip apart from 2.0 centimetres, are dripped 12 droplets/minute of speed, and liquid coolant is that liquid paraffin is a coolant, adopt drop pill machine-processed 1000 of 30 milligrams/ball drop pill.
Beneficial effect
The stasis expelling vessel freeing drip pill prescription is based on theory of Chinese medical science, with reference to ancient prescription " keeping out it " Fang Yi, best prescription has been found out in repetition test and clinical practice surplus ten year, adopting modern preparation technique. its innovation part is to utilize solid dispersions technique to prepare drop pill, reach modernization of Chinese medicine level, improve drug bioavailability, reduce drug dose, created a novel form that curative effect is outstanding, make this product curative effect more reliable, treat more thoroughly, can reach treating both the principal and secondary aspects of a disease, filled up the blank of stasis expelling vessel freeing drip pill dosage form.
The specific embodiment
The concrete mode of the present invention is identical with technical scheme, and this repeats no more.Prescription is 1000 amounts.Usage and dosage: oral, a 2-4 grain, an order 3 times.

Claims (1)

1. a Chinese medicine stasis expelling vessel freeing drip pill that is used for the treatment of cardiovascular and cerebrovascular disease is characterized in that adopting polyethylene glycol 6000 water solublity solid state substrate; Water intaking trematodiasis 500g, Tabanus 20g, Semen Persicae 41.7g, Radix Et Rhizoma Rhei 106.7g pulverize, and press incremental method and mix, and add 5 times water, soaked 24 hours, and in 40 ℃ of supersound process 20 minutes, filtration; Filtering residue concentrates with 70% ethanol, gets extractum, and drying is ground into medicated powder; Press 1: 2.4 mixing of Chinese medicine dry extract medicated powder and substrate, control material temperature is in 90 ℃, and 70 ℃ of condensation temperatures with 2.0 centimetres of distances, are dripped 12 droplets/minute of speed, and liquid paraffin is a coolant, adopts machine-processed 1000 of the 30 milligrams/ball drop pill that get of drop pill.
CNB200510127400XA 2005-12-28 2005-12-28 Stasis expelling vessel freeing drip pill Active CN100374130C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200510127400XA CN100374130C (en) 2005-12-28 2005-12-28 Stasis expelling vessel freeing drip pill

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200510127400XA CN100374130C (en) 2005-12-28 2005-12-28 Stasis expelling vessel freeing drip pill

Publications (2)

Publication Number Publication Date
CN1823952A CN1823952A (en) 2006-08-30
CN100374130C true CN100374130C (en) 2008-03-12

Family

ID=36934892

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200510127400XA Active CN100374130C (en) 2005-12-28 2005-12-28 Stasis expelling vessel freeing drip pill

Country Status (1)

Country Link
CN (1) CN100374130C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102225076B (en) * 2011-06-14 2012-10-10 重庆时珍阁普生药业有限公司 Modified Maixuekang preparation, modified Maixuekang enteric-coated preparation as well as preparation methods and applications thereof
CN103505532B (en) * 2013-10-10 2015-02-25 北京康远制药有限公司 Traditional Chinese medicinal granules capable of removing blood stasis and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051019C (en) * 1997-09-18 2000-04-05 鹤岗圣尔药业有限公司 Capsule for removing blood stasis and activating blood flow
CN1506097A (en) * 2002-12-10 2004-06-23 浙江得恩德制药有限公司 Chinese medicine capsule for treating ischemic cerebral apoplexy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051019C (en) * 1997-09-18 2000-04-05 鹤岗圣尔药业有限公司 Capsule for removing blood stasis and activating blood flow
CN1506097A (en) * 2002-12-10 2004-06-23 浙江得恩德制药有限公司 Chinese medicine capsule for treating ischemic cerebral apoplexy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
国家新药注册数据. 国家药品监督管理局药品注册司,药品审评中心,WS-094(Z-013)97,电子工业出版社. 2001 *
逐瘀通脉滴丸药理药效学研究. 于敏等.黑龙江医药科学,第28卷第5期. 2005 *

Also Published As

Publication number Publication date
CN1823952A (en) 2006-08-30

Similar Documents

Publication Publication Date Title
CN101485870A (en) Medicament for promoting digestion and expelling intestinal parasites
CN103223104B (en) A kind of Chinese medicine composition treating diabetes and preparation method thereof
CN100374130C (en) Stasis expelling vessel freeing drip pill
CN102085247A (en) Medicinal drop pills having effects of nourishing blood, eliminating blood stasis, soothing the liver and regulating menstruation
CN101979031B (en) Medicament for treating hemorrhoids and preparation method thereof
CN100409869C (en) Externally-applied medicinal liquid for treating dermatosis
CN100375608C (en) Tortoise-astragalus root-ginseng dripping pill and its preparing method
CN100375614C (en) Dripping pills with jaundice eliminating liver protecting functions and its preparation method
CN101264195A (en) Compound dragon's blood gel preparations and extraction and preparation technique
CN105250427A (en) Pharmaceutical composition for treating heart diseases
CN104922295A (en) Blood-nourishing and blood-enriching traditional Chinese medicine composition
CN104547588B (en) A kind of preparation method of stomach health drop pills
CN101020016A (en) Medicine for treating fracture and injured tendon and its prepn
CN103494916B (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN112402515A (en) Chinese medicinal extract containing insect medicine and preparation method of preparation thereof
CN102085254A (en) Codonopsis pilosula, radix astragali and kadsura longepedunculata dripping pill
CN102824407B (en) A kind of Chinese medicine dripping pills for the treatment of arthralgia aggravated by cold and preparation method thereof
CN103494894A (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN100382788C (en) Drop pill for treating hematuresis and process for preparing the same
CN100398098C (en) Ganoderma astragalus drip pill for treating heart spleen vacuity and its preparation method
CN102430029B (en) A kind of nano microcapsule for six ingredients with rehmannia and preparation technology thereof
CN101904906B (en) Rhizoma corydalis pain-relieving dripping pill preparation and preparation process thereof
CN102847085A (en) Preparation process and production method for Magnolia Officinalis Seven-Ingredient Decoction preparation in an integrated new dosage form
CN100348178C (en) 'Ganjing' dripping pills for treating liver disease and its preparation
CN1265831C (en) Compound ginseng saponin biological preparation for inhibiting tumour and its preparation method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant